EVALUATION UTERINE FIBROIDS TREATMENT USING RADIO FREQUENCY ABLATION AT HANOI OBSTETRICS AND GYNECOLOGY Objectives: To evaluate the results

Văn Vũ Dương, Thị Anh Đào Lê, Duy Ánh Nguyễn

Main Article Content

Abstract

Objectives: To evaluate the results of treatment of uterine fibroids by Radio Frequency Ablation (RFA) at Hanoi Obstetrics and Gynecology Hospital, Vietnam (HOGH) during 6 months. Materials and Methods: Patients with symptomatic uterine fibroids including abnormal uterine bleeding, pelvic pain, anemia; in need of preserving fertility; without any RFA contra-indications. A cross-sectional study with longitudinal follow-up. Results: 18 patients with 20 fibroids were met with the study’s inclusion criteria. The average fibroid size was 4.6±1.3 cm. 77,8% of patients having anemia. Average thermal ablation time was 12.2±4.1 minutes. Fibroids’ size decreased 43.6% after 1 month, 69.6% after 3 months and 83.6% after 6 months. Menstrual disorders and pelvic discomfort were considerably improved after 1month and 3 months. Conclusions: RFA had good initial results in reducing fibroids size and improving relating symptoms during the study period.

Article Details

References

1. Christoffel L., Bends R., Toub D., et al. (2022). Pregnancy Outcomes After Transcervical Radiofrequency Ablation of Uterine Fibroids with the Sonata System. J Gynecol Surg, 38(3), 207–213.
2. Fasciani A., Turtulici G., Siri G., et al. (2020). A Prospective Intervention Trial on Tailored Radiofrequency Ablation of Uterine Myomas. Medicina (Kaunas), 56(3), 122.
3. Bradley L.D., Pasic R.P., and Miller L.E. (2019). Clinical Performance of Radiofrequency Ablation for Treatment of Uterine Fibroids: Systematic Review and Meta-Analysis of Prospective Studies. J Laparoendosc Adv Surg Tech A, 29(12), 1507–1517.
4. Lee B.B. (2002). Radiofrequency Ablation of Uterine Leiomyomata: A New Minimally Invasive Hysterectomy Alternative. Obstetrics & Gynecology, 99(4).
5. Bergamini V., Ghezzi F., Cromi A., et al. (2005). Laparoscopic radiofrequency thermal ablation: a new approach to symptomatic uterine myomas. Am J Obstet Gynecol, 192(3), 768–773.
6. Bongers M., Brölmann H., Gupta J., et al. (2015). Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate® System: three- and six-month endpoint results from the FAST-EU study. Gynecol Surg, 12(1), 61–70.